Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry
Authors
Keywords
Anti-angiogenic therapy, Chemotherapy, Elderly patients, Overall survival, Progression-free survival
Journal
BMC GASTROENTEROLOGY
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-03-25
DOI
10.1186/1471-230x-14-53
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study
- (2013) H.-T. Tsai et al. ANNALS OF ONCOLOGY
- Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000–2008
- (2013) Tomáš Pavlík et al. Cancer Epidemiology
- Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
- (2013) David Cunningham et al. LANCET ONCOLOGY
- Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study
- (2013) Claudia Allemani et al. BMJ Open
- Bevacizumab in older patients with advanced colorectal or breast cancer
- (2012) Giuseppe Aprile et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Effectiveness of Bevacizumab With First-Line Combination Chemotherapy for Medicare Patients With Stage IV Colorectal Cancer
- (2012) Jeffrey A. Meyerhardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C
- (2011) T. J. Price et al. ANNALS OF ONCOLOGY
- Biologic therapies in the metastatic colorectal cancer treatment continuum – Applying current evidence to clinical practice
- (2011) Marc Peeters et al. CANCER TREATMENT REVIEWS
- Targeted agents: review of toxicity in the elderly metastatic colorectal cancer patients
- (2011) Flora Kyriakou et al. Targeted Oncology
- Clinical Outcomes in Elderly Patients with Metastatic Colorectal Cancer Receiving Bevacizumab and Chemotherapy: Results from the BRiTE Observational Cohort Study
- (2010) Mark F. Kozloff et al. ONCOLOGY
- Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
- (2009) James Cassidy et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcomes Associated with Bevacizumab-Containing Treatment of Metastatic Colorectal Cancer: The BRiTE Observational Cohort Study
- (2009) M. Kozloff et al. ONCOLOGIST
- Addition of Bevacizumab to Fluorouracil-Based First-Line Treatment of Metastatic Colorectal Cancer: Pooled Analysis of Cohorts of Older Patients From Two Randomized Clinical Trials
- (2008) Fairooz F. Kabbinavar et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started